AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On June 2, 2025,
(UTHR) saw a trading volume of $189 million, marking a 33.16% decrease from the previous day. This placed the company at the 499th position in terms of trading volume for the day. The stock price of United Therapeutics rose by 2.08%.United Therapeutics has been assigned an "Overweight" rating by
Fitzgerald, a leading financial services firm. This rating reflects a positive outlook on the company's future performance and potential for growth. The average rating for United Therapeutics is overweight, with a mean price target of $401.80, according to analysts polled by FactSet. This indicates a strong consensus among analysts regarding the company's prospects.Cantor Fitzgerald analyst Olivia Brayer initiated coverage on United Therapeutics, further supporting the positive sentiment surrounding the company. The initiation of coverage by a reputable firm like Cantor Fitzgerald is often seen as a vote of confidence in the company's future performance. This move is likely to attract more investor attention and potentially drive further stock price appreciation.
Hunt down the stocks with explosive trading volume.

Dec.22 2025

Dec.22 2025

Dec.22 2025

Dec.22 2025

Dec.22 2025
Daily stocks & crypto headlines, free to your inbox
How might XRP's current price consolidation near $1.92 be influenced by recent ETF inflows and market sentiment?
How can investors capitalize on the historic rally in gold and silver?
How might the gold and silver rally in 2025 impact the precious metals sector?
What are the strategic implications of gold outperforming Bitcoin in 2025?
Comments
No comments yet